CLINICAL_TRIALS
research
· 2025-08-03
Clinical Trial Update: Pharmacokinetics of Oral Letermovir in Adults With End-Stage Kidney Disease With or Without Haemodialysis [Phase 1]
Summary
Phase 1 pharmacokinetic study to assess oral letermovir disposition in adults with end-stage kidney disease, with or without haemodialysis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jason A Roberts | Conditions: End-Stage Kidney Disease (ESKD) | Phase 1 | Status: NOT_YET_RECRUITING